- Global Pharma News & Resources

Migraine Drugs Market Analysis By Top Players, Share And Forecast Upto 2028

Migraine is a neurological condition that can cause multiple symptoms which includes severe, recurring, and painful headaches. A migraine can cause severe throbbing pain or a pulsing sensation, usually on just one side of the head. It’s often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. There are a huge range of medications available to treat migraine. Some of these medications are available over the counter as well as prescription medications.

The global migraine drugs market is expected to register significant growth in the forecoming years. Major factors driving growth of the global migraine drugs markets are, increasing prevalence of migraine. In addition, instances of chronic and lifestyle diseases, changing life style, rising consumption of unhealthy food are the factors boosting the demand for migraine drugs.

The global migraine drugs market report has been segmented on the basis of treatment, route of administration, distribution channel, and region.

On the basis of treatment, the global migraine drugs market has been segmented into abortive or acute and prophylactic or preventive. On the basis of route of administration, the global migraine drugs market has been segmented into oral, injectable, and others includes nasal spray, transdermal patch, etc. On the basis of region, the global migraine drugs markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

In 2018, North America migraine drugs market is expected to account for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period. This is primarily attributed, due increasing incidence of chronic diseases and disorders in the region. However, Asia Pacific migraine drugs market is projected to register highest CAGR in the next five years, due to demand for better quality therapy and number of health conscious population in the region.

Get Free Sample Copy Of This Research @

Key players operating in the global migraine drugs market include AstraZeneca Plc., Allergan Plc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Eli Lilly & Co., Novartis AG, Merck & Co., Inc., Valeant Pharmaceutical International, Inc., and Janssen Pharmaceutical Company (Johnson & Johnson).

An Aim of Global Market report is as follows:

-To gives market insight across the world.
-To calculate and forecast the market on the basis of various segments.
-To provides market size and foreseen up to 2028 for overall market relevant to key regions.
-To study market dynamics influencing the market during the projection period 2019-2028 i.e. opportunities, risk, threats, drivers, restriction, and current/future trend.
-To offers broad SWOT analysis for all regions included in the report.
-To overview on major players performing in the industry along with their PESTEL study and market policies.

Editor Details

Last Updated: 19-Feb-2019